Finance

Lists
380550:KOSDAQ
Neurophet Inc
â‚©7,810.00
-1.14%
(-90.00) 1D
Jul 27, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 380550...
Open
â‚©7,970
High
â‚©8,340
Low
â‚©7,770
Mkt. cap
95.27B
Avg. vol.
110.05K
Volume
45.11K
52-wk high
â‚©36,700
52-wk low
â‚©7,280
EPS
-â‚©2,136
Shares outstanding
12.20M
No. of employees
135
Open
â‚©7,970
High
â‚©8,340
Low
â‚©7,770
Mkt. cap
95.27B
Avg. vol.
110.05K
Volume
45.11K
52-wk high
â‚©36,700
52-wk low
â‚©7,280
EPS
-â‚©2,136
Shares outstanding
12.20M
No. of employees
135
News stories
From sources across the web
About Neurophet Inc
CEO-
Employees135
Founded2016
Headquarters-
SectorHealth care
Websiteneurophet.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2025
Mar 2026
Revenue
534.10M
481.42M
Cost of goods sold
13.10M
3.81M
Cost of revenue
13.10M
3.81M
Research and development expenses
1.52B
2.13B
Total research and development expenses
-
-
Selling, general, and admin expenses
3.27B
3.82B
Operating expense
5.12B
6.29B
Total operating expenses
5.13B
6.30B
Operating income
-4.59B
-5.82B
Other non operating income
283.86M
524.66K
EBT including unusual items
-4.83B
-5.74B
EBT excluding unusual items
-4.83B
-5.74B
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
42.31M
20.83M
Net income
-4.83B
-5.74B
Net profit margin
-905.12%
-1,192.65%
Earnings per share
-
-
Interest and investment income
56.36M
128.37M
Interest expense
-579.09M
-62.03M
Net interest expenses
-522.73M
66.34M
Depreciation and amortization charges
232.83M
253.47M
EBITDA
-4.32B
-5.53B
Gain or loss from assets sale
-123.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer